SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TheSlowLane who wrote (156)5/20/1997 8:13:00 PM
From: NeuroInvestment   of 675
 
Re: the patent question. I have explored this further, including talking to CNSI management. They are very confident that all necessary patent bases are covered for GGF, and none of the current corporate suitors have concerns in this area. The 'rumor' was accurate in that a previous suitor had apparently spent considerable time exploring the patent position and potential competition thereto, but this ended up a moot point. I am not planning to pursue this any further, it appears to be a minor historical point. It has not affected the NeuroInvestment recommendation of CNSI, which is primarily founded on optimism about Cerestat. NeuroInvestment
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News